Dr Debra Patt: Telemedicine’s Contribution to Cancer Care Robust and Meaningful
COVID-19 accelerated telemedicine in oncology, leading to lasting improvements that will continue to benefit patient care post-pandemic.
Debra Patt, M.D., Ph.D., MBA, Executive Vice President, Public Policy, Payer Relations, and Strategic Initiatives at Texas Oncology, discusses how COVID-19 prompted advancements in telemedicine that have resulted in long-term and important changes in oncology care, as well as how these improvements will continue post-pandemic.
Read full article here.
Read full article here.